Investing in the future: stimulation of the medial prefrontal cortex reduces discounting of delayed rewards

Neuropsychopharmacology. 2015 Feb;40(3):546-53. doi: 10.1038/npp.2014.211. Epub 2014 Aug 29.

Abstract

Generally, rewards that are received sooner are often preferred over future rewards, and the time between the choice and the reception of the reward is an important factor that influences our decisions, a phenomenon called delay discounting (DD). In DD, the medial prefrontal cortex (MePFC) and striatal dopamine neurotransmission both play an important role. We used repetitive transcranial magnetic stimulation (rTMS) to transiently activate the MePFC to evaluate its behavioral effect on the DD paradigm, and subsequently to measure its effect on striatal dopamine. Twenty-four right-handed young healthy subjects (11 females; age: 22.1±2.9 years) underwent DD following 10 Hz-rTMS of the MePFC and vertex stimulation (control condition). Thereafter, 11 subjects (5 females; age: 22.2±2.87 years) completed the PET study at rest using [(11)C]-(+)-PHNO following 10 Hz-rTMS of the MePFC and vertex. Modulation of the MePFC excitability influenced the subjective level of DD for delayed rewards and interfered with synaptic dopamine level in the striatum. The present study yielded findings that might reconcile the role of these areas in inter-temporal decision making and dopamine modulation, suggesting that the subjective sense of time and value of reward are critically controlled by these important regions.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbon Radioisotopes / metabolism
  • Corpus Striatum / metabolism
  • Delay Discounting / physiology*
  • Dopamine / metabolism
  • Female
  • Functional Neuroimaging
  • Humans
  • Male
  • Oxazines / metabolism
  • Positron-Emission Tomography
  • Prefrontal Cortex / metabolism
  • Prefrontal Cortex / physiology*
  • Reward*
  • Transcranial Magnetic Stimulation*
  • Young Adult

Substances

  • Carbon Radioisotopes
  • Oxazines
  • naxagolide
  • Dopamine